IMAP France advises Biogroup on its acquisition of Oriade-Noviale group
Biogroup continued its development in France thanks to its merger with Oriade-Noviale/GLBM, a major player in medical biology in the Auvergne-Rhône-Alpes region.
Oriade-Noviale/GLBM, a group owned by its biologists, is positioned as a major player in medical biology in the Auvergne-Rhône-Alpes region. Operating 55 laboratories as well as 4 technical platforms, mainly in the departments of Isère, Loire and Haute-Savoie, Oriade-Noviale/GLBM achieved a turnover of approximately €100 million in 2019.
Bedankt voor je interesse in IMAP. Gebruik onderstaande formulier om ons meer te vertellen over je huidige situatie, dan zorgen wij ervoor dat de juiste M&A expert zo snel mogelijk contact met je opneemt.
